# Observational Study to Assess a 6-months Treatment With Gladem

> **NCT02231268** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 546 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Gladem

## Key facts

- **NCT ID:** NCT02231268
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2003-01
- **Final completion:** —
- **Target enrollment:** 546 (ACTUAL)
- **Last updated:** 2014-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231268, "Observational Study to Assess a 6-months Treatment With Gladem". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02231268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*